Glucagon in portal hypertension (Q40634973)

22 September 2017

1 reference

title

Glucagon in portal hypertension (English)

1 reference

22 September 2017

1 reference

Pak JM

1

1 reference

PubMed ID

7930485

22 September 2017

Lee SS

series ordinal

2

1 reference

22 September 2017

1 June 1994

1 reference

22 September 2017

Journal of Hepatology

1 reference

22 September 2017

20

1 reference

22 September 2017

6

1 reference

22 September 2017

825-832

1 reference

The cardiac output at rest in Laennec's cirrhosis

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Circulatory changes in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Effect of Portal Venous Blood Flow Diversion on Portal Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Cardiovascular effects of glucagon in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

The effect of glucagon on hepatic blood flow. An experimental study in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Hemodynamic responses to glucagon: an experimental study of central, visceral and peripheral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Splanchnic Hemodynamic Responses to Glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Glucagon: hemodynamic action related to the effect on K+ and Na+ metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Elevated plasma glucagon levels in cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Inability of glucagon to increase glomerular filtration rate in dogs with experimental cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Transhepatic hormone levels in the portacaval shunted pig—the effects of arginine upon gastrin and glucagon release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Hemodynamic effects of glucagon in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Circulatory changes induced by portal venous diversion and mesenteric hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

The role of the liver in glucagon metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Insulin and glucagon production in experimental cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Effects of glucagon on systemic and splanchnic circulation in conscious rats with biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Modification by glucagon of the splanchnic vascular responses to activation of the sympathicoadrenal system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

The inhibition by glucagon of the vasoconstrictor actions of noradrenaline, angiotensin and vasopressin on the hepatic arterial vascular bed of the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Responses of the simultaneously-perfused hepatic arterial and portal venous vascular beds of the dog to histamine and 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Intestinal vascular sensitivity to vasopressin in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

The effect of glucagon on vasoconstriction and vascular escape from nerve- and norepinephrine-induced constriction of the hepatic artery of the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Splanchnic hemodynamics in chronic portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Intestinal microvascular adaptation to chronic portal hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Protein-mediated elevations in renal hemodynamics: existence of a hepato-renal axis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Studies on the mechanism of action of glucagon in strips of rabbit renal artery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Relaxation by glucagon of potassium contracture in cat ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Modulation of cytosolic-[Ca2+] oscillations in hepatocytes results from cross-talk among second messengers. The synergism between the alpha 1-adrenergic response, glucagon and cyclic AMP, and their antagonism by insulin and diacylglycerol manifest t

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Atrial natriuretic factor. Possible implications in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Serotonin blockade in conscious, unrestrained cirrhotic dogs with portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Cardiovascular responses to serotonin in experimental liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Cardiac performance in the portal vein-stenosed rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

1 reference

7 January 2021

Somatostatin (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Hemodynamic studies in long- and short-term portal hypertensive rats: the relation to systemic glucagon levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

Effects of food intake and various extrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed Doppler with the Octoson.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980156-4

7 January 2021

10.1016/S0168-8278(05)80156-4

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

7930485